Multiple myeloma is a “geriatric disease”, and as China gradually enters an aging society, the number of elderly people has increased, resulting in a corresponding increase in the number of patients seen. The current conventional regimen of chemotherapy drugs, Vanco and hormones, on the one hand, is costly and unaffordable for some patients’ families, and on the other hand, some patients develop serious bacterial, fungal and viral infections after chemotherapy, which may even endanger their lives. Therefore, we actively explore the use of Chinese medicine treatment for patients of advanced age, with serious infections, important organ diseases and limited financial affordability to reduce complications and early mortality, and also greatly reduce the cost of treatment. In the past year, we have treated more than a dozen such patients with our original integrated Chinese medicine treatment method, and one half of them have experienced significant decreases in myeloma cells and immunoglobulins, remission of clinical symptoms of bone pain, fever, and anemia after 1-3 months of treatment, and some have achieved complete remission, including the three most refractory patients with plasma cell leukemia, and we are currently conducting in-depth studies to further refine this treatment.